Australia, Aug. 16 -- Madrigal Pharmaceuticals Inc., owns the trademark (2536567) for 'MADRIGAL' till Feb. 3, 2035.
Status: protected:
Registered/protected
Classes: 5 [Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.], 45 [Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties.], 05 [Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis] and 45 [Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties]
Type of Mark: Word
Date of Acceptance: April 4
Registration Advertised: Aug. 15
For further details contact Anita B. Polott Morgan, Lewis & Bockius LLP .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2536567.
Disclaimer: Curated by HT Syndication.